Tranexamic Acid in Pediatric Idiopathic Scoliosis Surgery

Recruiting N/A Interventional Study
Scoliosis Idiopathic Scoliosis; Adolescence
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
10 – 18
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
90 (estimated)
Sponsor
Poznan University of Medical Sciences · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study will evaluate whether tranexamic acid (TXA), a medication used to reduce bleeding, is effective and safe in children undergoing surgery for idiopathic scoliosis. Significant blood loss is common during this type of surgery and often requires blood transfusions. Participants will be randomly assigned to one of three groups: (1) TXA given as an intravenous bolus followed by continuous in…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 10 to 18 years * Diagnosis of idiopathic scoliosis requiring surgical correction (posterior spinal fusion) * American Society of Anesthesiologists (ASA) physical status I-II * Written informed consent from parents or legal guardians and assent from the child Exclusion Cri…
Contacts

Malgorzata Reysner, MD PhD

+48 61 831-01-22

mreysner@ump.edu.pl

CONTACT

Piotr Janusz, MD PhD

pjanusz@um.edu.pl

CONTACT